Friday, February 27, 2015

Weekly Links February 27 ,2015

“MUST READ”
o    Qu’est-ce que l’épigénétique ? Dans cet entretien Edith Heard, professeur au Collège de France, explique la particularité de cette discipline relativement récente qui s’intéresse au devenir génétique de nos cellules et représente un nouvel espoir dans la recherche contre le cancer.
o    But now, thanks to scientific advances such as genetic sequencing and new DNA editing technologies, the industry is in the midst of a dramatic reversal. Last year investors poured $3.3 billion into firms that are developing drugs for brain-destroying or psychiatric illnesses, more than in any of the last ten years, says NeuroPerspective.
DISRUPTION, REVOLUTION
TOOLS/TECHNIQUES
o    If you want to get the maximum yield and quality from your next-generation sequencing experiment then you are going to need to make sure each of the libraries you produce is carefully quantified ready for pooling and/or loading onto a flow cell. If the quantification goes wrong you’ll get a bad balance of samples within your pool, and if the loading goes wrong you might get no data at all!
o    In this article I’ll explain the pro’s and con’s of using qPCR and also discuss some of the other methods people use; these come with an advisory warning to avoid unless you really understand their limitations!
o    In a paper in Lab on a Chip, scientists from Corning, Inc. and Massachusetts General Hospital demonstrate a new, microengineered approach for treating cultured cells with drugs. Instead of growing the cells on flat surfaces, cells are grown on micro-modified wells plates that contain regular patterns of tiny holes.
o    Read any flow cytometry protocol and somewhere near the beginning will state something to the effect of ‘Place 1 million cells into a tube.’ The question is, faced with that special sample for THE experiment, how do you determine the number of cells in the tube? First we'll give a bit of information on why it is important to know the number of cells you have.
o    Bacterial cultures may be much easier to grow than mammalian cells, but if your yields are suboptimal there are plenty of parameters to play with. Here we list a few of the things you should consider to maximize your culture growth.

HEALTH/MEDECINE
COMPANIES
o    Unchained Labs is committed to building the next cool life science tools company. One that matters. One without old school rules. One with products that'll make a real difference in the research scientists do every day. 
The first Unchained product, Optim, lets scientists unlock optimal biologic formulations simply and quickly. For the first time, researchers can measure multiple protein stability parameters - including denaturing temperature and aggregation onset temperature - on multiple samples simultaneously. Assays are high throughput, label-free, ultra-low volume and very easy to run. 
SOMETHING DIFFERENT
o    Employees are vastly more satisfied and productive, it turns out, when four of their core needs are met: physical, through opportunities to regularly renew and recharge at work; emotional, by feeling valued and appreciated for their contributions; mental, when they have the opportunity to focus in an absorbed way on their most important tasks and define when and where they get their work done; and spiritual, by doing more of what they do best and enjoy most, and by feeling connected to a higher purpose at work.

Sunday, February 22, 2015

Weekly Links February 22 ,2015

“MUST READ”
o    More than 200 scientists working on an ambitious federal project have begun to understand the complicated system of switches that regulates genes, turning some on and others off, making some glow brightly while others dim. They hope these discoveries, described in two dozen papers released on Wednesday, will eventually lead to a deeper understanding of diseases and new ways to treat or cure them.
o    ast Friday, in a speech at the White House, President Obama unveiled what he called his Precision Medicine Initiative, a two-hundred-and-fifteen-million-dollar plan to collect genetic information from a million American volunteers in order to further the development of personalized, genetics-based medical treatments. Obama called precision medicine “one of the greatest opportunities for new medical breakthroughs that we have ever seen,” saying that it promised to deliver “the right treatments at the right time, every time, to the right person.”
DISRUPTION, REVOLUTION
o    Could genetically modified bacteria escape from a laboratory or fermentation tank and cause disease or ecological destruction?
This is not known to have occurred. But two groups of scientists reported on Wednesday that they had developed a complex technique to prevent it from happening.
TOOLS/TECHNIQUES
o    Imagine if antibodies were standardized with respect to their sequences, their concentrations, and their buffers. Antibodies would inspire confidence, not doubt. And we could stop wasting huge sums on “bad” antibodies. Worldwide, the losses mount to $800 million each year, roughly half the spending on protein-binding reagents. In the United States, the corresponding figure is $350 million.
o    I've been asked about the difference between the Illumina sequencer line-up so many times that I put together a spreadsheet to help the discussions. This is cobbled together from the Illumina website and there are no prices quoted, however I have estimated the £ per M reads and the £ per GB.
HEALTH/MEDECINE

COMPANIES
o    Transcriptic is a very small company. We like it that way. A key metric at Transcriptic is leverage: the employees-to-revenue ratio. We believe that a small, highly effective team supported by a large automation deployment can rewrite life science economics.
o    NextCODE said today it has been acquired by Shanghai’s WuXi Pharmatech for $65 million in cash. WuXi will merge NextCODE and its own genome center into a new company called WuXi NextCODE Genomics that will be headquartered in Shanghai yet have offices in Cambridge, MA, and Reykjavik, Iceland (
Under the collaboration, Sigma-Aldrich will provide the Transgenic Module at IMG/CCP with Sigma CRISPR technology, including reagents, experimental design consultation and dedicated gene editing bioinformaticians.
SOMETHING DIFFERENT


Monday, February 2, 2015

Weekly Links February 2 ,2015



“MUST READ”
    • In order to reach their lofty goal, the scientists are embarking on a massive experiment to sequence both the DNA and RNA of major food ingredients in various environments. To start with, they are examining things like poultry meal, fish meal, egg powder, and ground corn and will track them in the factory ecosystem, as they ship out, and even through different weather conditions.
DISRUPTION, REVOLUTION
    • Illumina once again used this platform as an opportunity to announce the release of a number of new products including 4 “New” sequencing systems ahead of the more scientifically focused Advances in Genome Biotechnology conference in February. 
    • There are a few important differences among these systems though.  The flagship HiSeq X can output 900 gigabases of data per flowcell in 3 days while the HiSeq 3000/4000 only output 750 gigabases
TOOLS/TECHNIQUES
tags: cultures bio
    • Bacterial cultures may be much easier to grow than mammalian cells, but if your yields are suboptimal there are plenty of parameters to play with. Here we list a few of the things you should consider to maximize your culture growth.
HEALTH/MEDECINE

COMPANIES
    • Cell-free protein expression, as is called the method Invenra and Sutro use, still requires all the “goo” —the protein-making machinery—from inside cells as the growing medium. But it doesn’t require the cells themselves. Once the right mix is in place, the next key ingredient to add is the DNA of the desired protein.
Much faster than conventional cell-based methods, cell-free expression has been available to researchers for years, but Sutro is likely the first biotech to scale it up into what could be a major therapeutic platform
    • Really what we want is to provide is a tool that allows you to provide a protein fingerprint, i.e. you can look at all the proteins that are in the human body so that it's the data that comes out about this protein that identifies the diagnostic. We would provide is something that provides a basis to develop the diagnosis first and then be the diagnostic afterwards.
SOMETHING DIFFERENT
    • But of all the ways that Uber could change the world, the most far-reaching may be found closest at hand: your office. Uber, and more broadly the app-driven labor market it represents, is at the center of what could be a sea change in work, and in how people think about their jobs. You may not be contemplating becoming an Uber driver any time soon, but the Uberization of work may soon be coming to your chosen profession.